Loading…
Data as of .
| Sector | Companies | Market cap | 1M (cap-wt) | 6M (cap-wt) | Median revenue growth | Median fwd P/E |
|---|---|---|---|---|---|---|
| Health Care | 29 | $971B | +12.9% | +21.3% | +1% | 31.0× |
| Financials | 30 | $503B | +5.7% | +12.8% | -2% | 15.2× |
| Industrials | 38 | $372B | -2.7% | +1.8% | 0% | 20.5× |
| Consumer Staples | 8 | $363B | +13.7% | +14.2% | 0% | 20.4× |
| Consumer Discretionary | 8 | $139B | +0.7% | +8.4% | -1% | 15.7× |
| Materials | 8 | $126B | +10.1% | +15.6% | -5% | 22.2× |
| Communication Services | 4 | $52.8B | +11.3% | +8.8% | +2% | 26.1× |
| Information Technology | 15 | $48.2B | -2.7% | +2.3% | +1% | 21.5× |
| Real Estate | 15 | $41.0B | +6.0% | -0.6% | +6% | 26.9× |
| Utilities | 3 | $11.0B | +5.2% | -13.9% | -5% | 14.1× |
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Roche RO.SW | Pharmaceuticals: Major | $385B | +11% | +22% | -1% | 31% | 19.6× |
| Novartis NOVN.SW | Pharmaceuticals: Major | $298B | +13% | +15% | -4% | 30% | 18.4× |
| Nestle NESN.SW | Food: Major Diversified | $266B | +13% | +11% | -2% | 16% | 19.0× |
| UBS UBSG.SW | Investment Managers | $148B | +2% | +13% | -5% | 23% | 13.2× |
| ABB ABBN.SW | Electrical Products | $147B | -15% | -17% | +1% | 18% | 24.5× |
| Compagnie Financiere Richemont CFR.SW | Other Consumer Specialties | $122B | +1% | +10% | +2% | 21% | 24.8× |
| Zurich Insurance ZURN.SW | Multi-Line Insurance | $114B | +10% | +16% | +19% | 11% | 16.8× |
| Lonza LONN.SW | Biotechnology | $55.4B | +18% | +39% | -11% | 25% | 36.1× |
| Galderma GALD.SW | Pharmaceuticals: Major | $54.8B | +18% | +17% | +16% | 19% | 48.1× |
| Swiss Re SREN.SW | Multi-Line Insurance | $50.6B | +7% | +27% | -12% | 14% | 11.1× |
| Holcim HOLN.SW | Construction Materials | $48.4B | +17% | -3% | -26% | 16% | 19.5× |
| Givaudan GIVN.SW | Household/Personal Care | $45.8B | +19% | +47% | -2% | 18% | 34.0× |
| Swisscom SCMN.SW | Major Telecommunications | $45.7B | +12% | +7% | +14% | 16% | 26.1× |
| Sandoz SDZ.SW | Pharmaceuticals: Major | $44.4B | +21% | +24% | +1% | 15% | 25.3× |
| Schindler SCHN.SW | Industrial Machinery | $39.4B | +19% | +17% | -3% | 13% | 28.2× |
| Alcon ALC.SW | Medical Specialties | $37.5B | +17% | +22% | -1% | 11% | 21.4× |
| Sika SIKA.SW | Chemicals: Major Diversified | $36.4B | +8% | +32% | -4% | 14% | 24.9× |
| Kuehne & Nagel International KNIN.SW | Marine Shipping | $34.3B | +5% | +35% | +1% | 5% | 25.4× |
| Swiss Life SLHN.SW | Life/Health Insurance | $33.0B | +10% | +14% | 0% | 18% | 20.4× |
| Helvetia Baloise HBAN.SW | Multi-Line Insurance | $27.0B | +8% | +5% | +54% | 4% | 18.9× |
| Sgs SGSN.SW | Miscellaneous Commercial Services | $24.8B | +8% | +21% | +5% | 15% | 24.5× |
| Chocoladefabriken Lindt & Spruengli LISN.SW | Food: Specialty/Candy | $24.6B | +10% | -8% | +4% | 16% | 28.2× |
| Ems-chemie EMSN.SW | Chemicals: Specialty | $24.3B | 0% | +28% | -3% | 30% | 39.4× |
| Geberit GEBN.SW | Engineering & Construction | $22.1B | +11% | +14% | +3% | 29% | 29.8× |
| Partners PGHN.SW | Investment Managers | $21.3B | +14% | -24% | +9% | 56% | 16.7× |
| Straumann STMN.SW | Medical Specialties | $20.4B | +19% | +25% | +2% | 21% | 31.9× |
| Sonova SOON.SW | Medical Specialties | $20.3B | +13% | +62% | -7% | 21% | 25.6× |
| VAT VACN.SW | Industrial Machinery | $19.0B | -23% | -11% | -2% | 25% | 48.2× |
| Julius Baer Gruppe BAER.SW | Financial Conglomerates | $17.1B | -4% | +2% | 0% | 30% | 11.3× |
| Banque Cantonale Vaudoise BCVN.SW | Regional Banks | $14.4B | +6% | +20% | -8% | 42% | 25.9× |
| Company | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|
| Meier Tobler MTG.SW | $610M | +35% | +41% | +2% | 4% | 22.6× |
| Medartis MED.SW | $1.83B | +34% | +47% | +30% | 2% | 74.2× |
| Sandoz SDZ.SW | $44.4B | +21% | +24% | +1% | 15% | 25.3× |
| DocMorris DOCM.SW | $1.02B | +21% | +136% | +11% | -8% | n/a |
| Barry Callebaut BARN.SW | $8.33B | +20% | +5% | +9% | 5% | 23.7× |
| R&S Group Holding AG Pref RSGN.SW | $899M | +19% | -22% | +2% | 18% | 14.6× |
| Straumann STMN.SW | $20.4B | +19% | +25% | +2% | 21% | 31.9× |
| Givaudan GIVN.SW | $45.8B | +19% | +47% | -2% | 18% | 34.0× |
| Schindler SCHN.SW | $39.4B | +19% | +17% | -3% | 13% | 28.2× |
| Galderma GALD.SW | $54.8B | +18% | +17% | +16% | 19% | 48.1× |
| Company | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|
| ams-OSRAM AMS.SW | $1.78B | -35% | -16% | -3% | 8% | n/a |
| VAT VACN.SW | $19.0B | -23% | -11% | -2% | 25% | 48.2× |
| INFICON IFCN.SW | $4.51B | -22% | 0% | -2% | 17% | 32.8× |
| LEM LEHN.SW | $768M | -18% | +74% | -6% | 9% | 20.0× |
| COMET COTN.SW | $2.84B | -16% | -9% | -3% | 6% | 34.0× |
| ABB ABBN.SW | $147B | -15% | -17% | +1% | 18% | 24.5× |
| Arbonia ARBN.SW | $322M | -14% | -4% | +9% | -1% | n/a |
| Huber + Suhner HUBN.SW | $3.49B | -13% | -44% | -4% | 9% | 30.9× |
| Sensirion SENS.SW | $1.46B | -13% | +3% | +1% | 12% | 35.3× |
| OC Oerlikon OERL.SW | $1.99B | -12% | +41% | -21% | 8% | 15.8× |